Tag: Meniere s disease

An estimated 615,000 Americans are diagnosed with Meniere's disease, and for many, a common medication prescribed to manage its symptoms is Merislon. So, what is merislon used for, and how does it help alleviate the debilitating effects of this inner ear disorder?.

According to a systematic review, specific pharmacological treatment for chronic vertigo is highly dependent on the underlying cause, and most acute medications are not suitable for long-term daily use. Deciding what can I take every day for vertigo requires an accurate medical diagnosis to form an effective, sustainable management plan.

The annual incidence of Sudden Sensorineural Hearing Loss (SSNHL) is estimated to be between 5 and 27 people per 100,000 [1.8.2]. This article explores a key question for those affected: How effective are steroid injections for hearing loss? Treatment timeliness is critical for success [1.2.1].

Although betahistine is a well-established treatment for Ménière's disease and vertigo, certain medical conditions mean it should be avoided completely or used with extreme caution. It is crucial to understand **who should avoid betahistine** to ensure patient safety and prevent serious complications, particularly for those with a rare adrenal gland tumor known as pheochromocytoma.

Despite being widely available in other countries for Meniere's disease and vertigo, Betahistine is not commercially sold in the United States, meaning pricing is not standardized. Instead of purchasing from a traditional pharmacy, US patients must obtain the medication either through a compounding pharmacy with a valid prescription or from international online pharmacies, fundamentally altering the answer to "how much is Betahistine in the US?".

Recent drug shortage reports from health authorities like Health Canada indicate multiple betahistine products have experienced significant supply disruptions. Patients relying on this medication for conditions like Meniere's disease are facing challenges understanding why there is a shortage of betahistine and what steps they can take to manage their condition.

Betahistine is widely prescribed for Meniere's disease and vertigo in more than 80 countries worldwide, yet its FDA approval was rescinded in the US during the 1970s due to a lack of substantial evidence of efficacy. This withdrawal was based on a reevaluation of clinical data, leaving many patients wondering why is betahistine no longer available in the United States.

While betahistine is widely used globally to treat symptoms of Ménière's disease, it is not an over-the-counter (OTC) medication in most countries, including the United States, where its sale is highly restricted. This prescription-only status is crucial for ensuring the drug is used under proper medical supervision for specific inner ear disorders.

While betahistine is widely used in more than 80 countries for managing vertigo, it has not been commercially available in the United States for decades. As such, there is no standardized US brand name for betahistine on the commercial market, though it may be obtained through specific channels.

Dizziness and balance problems affect about 15.5% of American adults, which translates to over 36 million people [1.6.1]. So, is there a pill that helps with balance? While no single pill directly improves balance, various medications can manage symptoms like vertigo and dizziness that stem from underlying conditions [1.2.1].